MX2015001007A - Composicion de misoprostol. - Google Patents
Composicion de misoprostol.Info
- Publication number
- MX2015001007A MX2015001007A MX2015001007A MX2015001007A MX2015001007A MX 2015001007 A MX2015001007 A MX 2015001007A MX 2015001007 A MX2015001007 A MX 2015001007A MX 2015001007 A MX2015001007 A MX 2015001007A MX 2015001007 A MX2015001007 A MX 2015001007A
- Authority
- MX
- Mexico
- Prior art keywords
- misprostol
- composition
- misoprostol
- methods
- î1⁄4g
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La presente invención se refiere al uso de misoprostol para la inducción del trabajo de parto en una mujer embarazada, y en particular al uso de un dispositivo o inserto de suministro sostenido que contiene sustancialmente 200 µg de misoprostol para el uso intravaginal. El uso comprende métodos de terapia así como también composiciones para el uso en estos métodos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12178079.5A EP2689781A1 (en) | 2012-07-26 | 2012-07-26 | Misoprostol composition |
EP13150702.2A EP2754442A1 (en) | 2013-01-09 | 2013-01-09 | Misoprostol for the induction of labour |
PCT/EP2013/065767 WO2014016394A1 (en) | 2012-07-26 | 2013-07-25 | Misprostol composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015001007A true MX2015001007A (es) | 2015-04-09 |
Family
ID=48856654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015001007A MX2015001007A (es) | 2012-07-26 | 2013-07-25 | Composicion de misoprostol. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20150174139A1 (es) |
EP (1) | EP2877181A1 (es) |
JP (2) | JP2015522646A (es) |
KR (1) | KR20150038174A (es) |
CN (1) | CN104507482A (es) |
AU (2) | AU2013294960B2 (es) |
CA (1) | CA2879772A1 (es) |
EA (1) | EA031594B1 (es) |
HK (1) | HK1210966A1 (es) |
IL (1) | IL236357A0 (es) |
MX (1) | MX2015001007A (es) |
WO (1) | WO2014016394A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3166597A2 (en) | 2014-07-11 | 2017-05-17 | Azanta Danmark A/S | Misoprostol dispersible tablet |
DK2965750T3 (en) | 2014-07-11 | 2017-10-16 | Azanta Danmark As | Misoprostol dispersible tablet |
US20160008310A1 (en) | 2014-07-11 | 2016-01-14 | Azanta A/S | Misoprostol dispersible tablet |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU537741B2 (en) | 1979-03-21 | 1984-07-12 | British Technology Group Limited | Controlled release compositions |
US20040044080A1 (en) | 1997-10-28 | 2004-03-04 | Place Virgil A. | Treatment of dyspareunia with topically administered nitroglycerin formulations |
US20020013304A1 (en) | 1997-10-28 | 2002-01-31 | Wilson Leland F. | As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
CA2358556C (en) | 1998-12-30 | 2006-10-31 | Peter Joannes Coenders | Diacetyl tartaric acid esters of mono- and diglycerides based on c12 to c22 fatty acids |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
US7263335B2 (en) * | 2004-07-19 | 2007-08-28 | Purewave Networks, Inc. | Multi-connection, non-simultaneous frequency diversity in radio communication systems |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
DE102004054552A1 (de) * | 2004-11-11 | 2006-05-18 | Hcb Happy Child Birth Holding Ag | Neue Zusammensetzung zur Erleichterung der Humangeburt |
WO2006089561A1 (en) * | 2005-02-23 | 2006-08-31 | Abbas Abdelsalam Ghazi | Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix. |
CN102939085B (zh) * | 2010-06-11 | 2016-05-04 | 辉凌公司 | 阴道内施用米索前列醇 |
-
2013
- 2013-07-25 WO PCT/EP2013/065767 patent/WO2014016394A1/en active Application Filing
- 2013-07-25 EP EP13740040.4A patent/EP2877181A1/en not_active Withdrawn
- 2013-07-25 AU AU2013294960A patent/AU2013294960B2/en not_active Ceased
- 2013-07-25 CA CA2879772A patent/CA2879772A1/en not_active Abandoned
- 2013-07-25 MX MX2015001007A patent/MX2015001007A/es unknown
- 2013-07-25 EA EA201492238A patent/EA031594B1/ru not_active IP Right Cessation
- 2013-07-25 CN CN201380039588.5A patent/CN104507482A/zh active Pending
- 2013-07-25 JP JP2015523557A patent/JP2015522646A/ja active Pending
- 2013-07-25 KR KR1020157004391A patent/KR20150038174A/ko active Search and Examination
- 2013-07-25 US US14/415,957 patent/US20150174139A1/en not_active Abandoned
-
2014
- 2014-12-18 IL IL236357A patent/IL236357A0/en unknown
-
2015
- 2015-12-03 HK HK15111917.0A patent/HK1210966A1/xx unknown
-
2016
- 2016-12-22 US US15/388,157 patent/US20170112854A1/en not_active Abandoned
-
2018
- 2018-06-27 JP JP2018121794A patent/JP2018184413A/ja not_active Withdrawn
- 2018-07-20 AU AU2018206847A patent/AU2018206847A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20170112854A1 (en) | 2017-04-27 |
IL236357A0 (en) | 2015-02-26 |
EA031594B1 (ru) | 2019-01-31 |
EA201492238A1 (ru) | 2015-06-30 |
KR20150038174A (ko) | 2015-04-08 |
US20150174139A1 (en) | 2015-06-25 |
EP2877181A1 (en) | 2015-06-03 |
WO2014016394A1 (en) | 2014-01-30 |
AU2013294960A1 (en) | 2015-01-22 |
AU2013294960B2 (en) | 2018-04-19 |
CA2879772A1 (en) | 2014-01-30 |
CN104507482A (zh) | 2015-04-08 |
AU2018206847A1 (en) | 2018-08-09 |
JP2015522646A (ja) | 2015-08-06 |
HK1210966A1 (en) | 2016-05-13 |
JP2018184413A (ja) | 2018-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015DN01156A (es) | ||
MX2014010455A (es) | Metodos y composiciones para tratar enfermedad de huntington. | |
MX352324B (es) | Vacunas multivalentes de nanovehiculos sinteticos. | |
MX2017001406A (es) | Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva. | |
GB201106743D0 (en) | Novel compounds | |
GB201106750D0 (en) | Novel compounds | |
MX2015010125A (es) | Derivados de piridazinona-amidas. | |
NZ727304A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
MX366899B (es) | Nuevos compuestos. | |
GB201118656D0 (en) | New compounds | |
MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
MX2021004211A (es) | Composiciones vacuna. | |
MX2013004061A (es) | Analogos de ciclosporina. | |
MX2016004556A (es) | Composicion de hueso comprimido y metodo para usar la misma. | |
MA39710A (fr) | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin | |
IN2014DN06104A (es) | ||
MX2015012741A (es) | Palbociclib deuterado. | |
MX367926B (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
MY191337A (en) | Compositions for the treatment of hypertension and/or fibrosis | |
MY172557A (en) | Compositions for the treatment of hypertension and/or fibrosis | |
IN2014DN07326A (es) | ||
MX2015001007A (es) | Composicion de misoprostol. | |
MX2015005111A (es) | Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada. | |
UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину |